Renowned Breast Surgeon Joins JWCI
The John Wayne Cancer Institute (JWCI) at St. John’s Health Center has announced that, Maureen Chung, M.D., PhD, FACS, will be the new medical director of the Margie Petersen Breast Center, director of the Breast Surgical Oncology Fellowship Program and director of the Margie and Robert E. Petersen Breast Cancer Research Program.
“Dr. Chung is an exemplary physician-researcher, educator and leader. Her breadth of expertise will enhance patient care; and her clinical research will help change the way breast cancer is diagnosed and treated,” said Lou Lazatin, president/CEO of JWCI and St. John’s.
A leader in the field of surgical oncology, Dr. Chung’s current research focuses on the role of a specific protein produced in breast cancer cells that can inhibit the effectiveness of chemotherapy. She is working on a nanoparticle system that permits simultaneous non-invasive visualization of breast cancers and targeted drug therapy.
Dr. Chung has also pioneered studies on breast-cancer vaccines, the contemporary management of breast cancer and the impact of mammographic screening on breast- cancer presentation, treatment and outcome.
“It is my goal to develop an inter-disciplinary breast center that is patient focused,” Dr. Chung explained. “It will integrate the clinical disciplines, but also address survivorship, nutrition and breast-cancer risk factors.”
Before joining JWCI, Dr. Chung was an associate professor of surgery at Brown University and a breast surgeon at Rhode Island Hospital.
A member of the board of directors of the Rhode Island Breast Cancer Coalition, Dr. Chung is also an associate editor of the American Journal of Clinical Oncology, an external grant reviewer for the Arkansas Breast Cancer Research Program and a contributing editor for Women’s Oncology Review.
“Dr. Chung is considered a triple threat in American surgery,” said Anton Bilchik, M.D., PhD, FACS, JWCI chief of medicine. “She is an outstanding surgeon, scientist and has a magnetic personality. She is considered one of the national leaders in breast surgery and many leading universities were interested in recruiting her. The addition of Dr. Chung to JWCI continues the tradition of excellence and breakthroughs in cancer care.
“Under her leadership the Breast Center at St. John’s will provide women the most comprehensive care for the screening, detection and treatment of breast diseases in Los Angeles.” Bilchik added.